蛋白質工程和發展

As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, optimizing lead and candidate selection, and the application of deep sequencing and single cell analysis.


1月20~21日

Recombinant Protein Therapeutics
( 重組蛋白質療法 )

1月21~22日

Lead and Candidate Selection for Therapeutic Proteins
( 治療用蛋白質的先導化合物和藥劑候補選擇 )

1月23~24日

Deep Sequencing and Single Cell Analysis for Antibody Discovery
( 抗體發現的深度定序和單一細胞解析 )


Keynote Speakers

Aris N. Economides, PhD, Vice President, Research, Regeneron Pharmaceuticals, Inc.


Peter M. Tessier, PhD, Professor, Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan


Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute


* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English






2020年會議節目和培訓研討會


免費電子郵件通知服務